Roopika Menon

7.7k total citations
31 papers, 756 citations indexed

About

Roopika Menon is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Roopika Menon has authored 31 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 17 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Roopika Menon's work include Lung Cancer Treatments and Mutations (10 papers), Prostate Cancer Treatment and Research (8 papers) and Molecular Biology Techniques and Applications (5 papers). Roopika Menon is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Prostate Cancer Treatment and Research (8 papers) and Molecular Biology Techniques and Applications (5 papers). Roopika Menon collaborates with scholars based in Germany, United States and United Kingdom. Roopika Menon's co-authors include Sven Perner, O.S. Alfi, George N. Donnell, Barbara F. Crandall, Falko Fend, Martin Braun, Veit Scheble, Johannes M. Heuckmann, Karen Petersen and Diana Boehm and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roopika Menon

31 papers receiving 740 citations

Peers

Roopika Menon

PRM

ONCOL

GENET

Shamini Selvarajah Canada

Kirsten Struckmann Switzerland

Shawn Yost United States

Ubaradka G. Sathyanarayana United States

Viktoria Evdokimova United States

Kimberly Lezon-Geyda United States

Annette Fasan Germany

Consuelo D'Ambrosio United States

Meng-Hong Sun China

Emily K. Slotkin United States

Shamini Selvarajah Canada

Roopika Menon

405 ×0.9

264 ×1.0

PRM

220 ×1.0

133 ×0.7

ONCOL

111 ×0.8

GENET

Citations per year, relative to Roopika Menon Roopika Menon (= 1×) peers Shamini Selvarajah

Countries citing papers authored by Roopika Menon

Since Specialization

Citations

This map shows the geographic impact of Roopika Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roopika Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roopika Menon more than expected).

Fields of papers citing papers by Roopika Menon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roopika Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roopika Menon. The network helps show where Roopika Menon may publish in the future.

Co-authorship network of co-authors of Roopika Menon

This figure shows the co-authorship network connecting the top 25 collaborators of Roopika Menon. A scholar is included among the top collaborators of Roopika Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roopika Menon. Roopika Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andrieu, Charlotte, Annemarie Larkin, Andrew Maguire, et al.. (2022). Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes. SHILAP Revista de lepidopterología. 10(2). 26–26. 1 indexed citations

Majewska, Hanna, Piotr Czapiewski, Roopika Menon, et al.. (2020). ALK alterations in salivary gland carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(5). 933–941. 17 indexed citations

Landi, Lorenza, Marcello Tiseo, Lukas C. Heukamp, et al.. (2019). P1.14-03 Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial. Journal of Thoracic Oncology. 14(10). S553–S553. 1 indexed citations

Malchers, Florian, Meryem S. Ercanoglu, Roberta Castiglione, et al.. (2017). Mechanisms of Primary Drug Resistance in FGFR1 -Amplified Lung Cancer. Clinical Cancer Research. 23(18). 5527–5536. 41 indexed citations

Falk, Markus, Erika Mariotti, Miriam Bertrand, et al.. (2017). Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens. Journal of Thoracic Oncology. 12(10). 1503–1511. 35 indexed citations

Michels, Sebastian, Andreas H. Scheel, Thomas Wündisch, et al.. (2017). ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor. npj Precision Oncology. 1(1). 4–4. 30 indexed citations

Menon, Roopika, Erika Mariotti, Judith Mueller, et al.. (2017). PUB053 Panel Based Hybrid Capture Sequencing Assay to Correlate Mutational Load with Response to Immunotherapy. Journal of Thoracic Oncology. 12(1). S1478–S1479. 1 indexed citations

Menon, Roopika, Sotirios Lakis, Kenneth S. Thress, et al.. (2016). A Novel EGFR C797 Variant Detected in a Pleural Biopsy Specimen from an Osimertinib-Treated Patient Using a Comprehensive Hybrid Capture–Based Next-Generation Sequencing Assay. Journal of Thoracic Oncology. 11(9). e105–e107. 25 indexed citations

Majewska, Hanna, Judith Müller, Sotirios Lakis, et al.. (2016). Abstract 3190: Genomic profiling of salivary gland tumors identifies novel and targetable alterations. Cancer Research. 76(14_Supplement). 3190–3190. 1 indexed citations

10.

Rooney, Claire, Catherine Geh, Victoria Williams, et al.. (2016). Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon. PLoS ONE. 11(2). e0149628–e0149628. 21 indexed citations

11.

Menon, Roopika, Maria A. Svensson, Jessica Carlsson, et al.. (2014). Prognostic significance of YWHAZ expression in localized prostate cancer. Prostate Cancer and Prostatic Diseases. 17(4). 310–314. 21 indexed citations

12.

Hart, Martin, Sven Wach, Elke Nolte, et al.. (2013). The proto‐oncogeneERGis a target of microRNAmiR‐145in prostate cancer. FEBS Journal. 280(9). 2105–2116. 56 indexed citations

13.

Menon, Roopika, Mario C. Deng, Angela Queisser, et al.. (2013). Somatic copy number alterations by whole‐exome sequencing implicates YWHAZ and PTK2 in castration‐resistant prostate cancer. The Journal of Pathology. 231(4). 505–516. 26 indexed citations

14.

Göke, Friederike, Alina Franzen, Roopika Menon, et al.. (2012). Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors. CHEST Journal. 142(4). 1020–1026. 45 indexed citations

15.

Wagner, Patrick, Theresia Wilbertz, Karen Petersen, et al.. (2011). Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer. 74(1). 118–123. 33 indexed citations

16.

Braun, Martin, Roopika Menon, Pavel Nikolov, et al.. (2011). The HOPE fixation technique - a promising alternative to common prostate cancer biobanking approaches. BMC Cancer. 11(1). 511–511. 26 indexed citations

17.

Braun, Martin, Veit Scheble, Roopika Menon, et al.. (2011). Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer. Histopathology. 58(7). 1028–1036. 31 indexed citations

18.

Maier, Sebastian H., Theresia Wilbertz, Martin Braun, et al.. (2011). SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Human Pathology. 42(8). 1078–1088. 95 indexed citations

19.

Menon, Roopika, et al.. (1984). Prostatic cancer treated by external irradiation at the Rotterdam Radiotherapy Institute.. PubMed. 160(5). 293–300. 10 indexed citations

20.

Alfi, O.S., et al.. (1973). Deletion of the short arm of chromosome no.9 (46,9p-): a new deletion syndrome.. PubMed. 16(1). 17–22. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact